Position in INSM
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$611,074
-$58,631 QoQ
Shares Held
3,737
-2.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 65.77468557666577.ToString("F0")%
Shared 0.ToString("F0")%
None 34.225314423334225.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $11,059,687 across 19 Biotechnology names. INSM ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,537 | $2,919,031 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,874 | $1,447,927 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
3,404 | $643,526 | |
| 4 | INSM |
INSMED Inc
This page
|
3,737 | $611,074 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
8,863 | $572,815 | |
| 6 | OMER |
Omeros Corp
|
54,130 | $571,612 | |
| 7 | MRNA |
Moderna, Inc.
|
8,859 | $450,037 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,351 | $447,005 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $611,074 | 3,737 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $669,705 | 3,848 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $650,925 | 4,520 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $500,684 | 4,975 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $360,927 | 4,731 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $245,161 | 3,551 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $254,770 | 3,490 | Shares | Sole | 2024-11-18 | |
| No filing history on record for this holder in this stock. | ||||||